Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance
NCT02614703Phase 3Terminated
- Sponsor
- DHR Health
- Start
- Mar 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of acetic acid in Barrett's esophagus (2 arms), sponsored by DHR Health. Primary endpoint: Total Number of Subjects With Neoplasia When Using Acetic Acid Chromoendoscopy Versus Standardized Random Biopsies. Started Mar 2017; status: terminated.
02
Drugs
acetic acid
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT02614703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02614703.